Learn More
  • S Barber
  • 1998
Allogeneic bone marrow transplantation is used increasingly as a treatment for haematological diseases. Pre-transplant conditioning is necessary to eradicate the host immune response, and post-transplant immunosuppressive therapy is continued to prevent graft-versus-host disease. Thus, bone marrow transplant recipients are severely immunocompromised for a(More)
  • 1